Published on: March 9, 2023 Applied Clinical Trials Watch the Full Interview >> Key Learning Objectives: Challenges people encounter when working with RWD How can RWD help address gaps in care? How OM1 engages or supports health equity research using RWD
Read the latest blog featuring Drs. Carl Marci & Joseph Zabinski in tHEORetically Speaking Written by: Undine McEvoy March 13, 2023 Mental health conditions can take a staggering toll on an individual physically, socially and financially. Many patients languish with partially effective or ineffective treatments, even though new options are constantly entering the market. At[…]
Utilizing unique AI modeling capabilities with the new datasets, the company commits to improving personalized treatment options and outcomes for patients BOSTON, March 2, 2023 — OM1 a leading real-world data, outcomes and technology company with a focus on chronic conditions, today announced the enhancement of its Mental Health and Neuroscience Real-World Data[…]
Watch the full interview from Healthcare IT about ChatGPT for un-diagnosed patients with Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1. The road to diagnosis can be taxing for patients and once diagnosed, personalized treatment plans are still created with an element of guess work. Automation and artificial intelligence (AI) are the[…]
Published: December 1, 2022 Rheumatology Network Read the Full Article >> In the wake of the Supreme Court’s decision to overturn Roe v Wade, results of a recent study indicated that more than half of female patients treated with methotrexate, a commonly-prescribed drug used to manage rheumatic diseases, lived in states with abortion restrictions or[…]
